Rhoifolin inhibited cell proliferation and promoted apoptosis of pancreatic cancer cells, which was associated with up-regulated JNK and p-JNK as well as down-regulated p-AKT. The gene discussed is MAPK8; the disease is familial pancreatic carcinoma.